N. Boyle

NEURONAL SORTING AND DEGRADATION OF TAU BY THE ENDOLYSOSOMAL PATHWAY AND RAB35 IN HIPPOCAMPAL PATHOLOGY

L. Grinberg, W. Seeley, C. Soares-Cunha, 2019, Alzheimer's & Dementia.

Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations

E. Roberson, N. Boyle, Shreya N. Kashyap, 2023, Neurotherapeutics.

Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations

Jonathan R Roth, W. Seeley, E. Roberson, 2019, Acta Neuropathologica Communications.

Reduction of microglial progranulin does not exacerbate pathology or behavioral deficits in neuronal progranulin-insufficient mice

E. Roberson, A. Filiano, A. Arrant, 2019, Neurobiology of Disease.

Patients with sporadic FTLD exhibit similar increases in lysosomal proteins and storage material as patients with FTD due to GRN mutations

W. Seeley, A. Arrant, S. Spina, 2023, Acta Neuropathologica Communications.

Development of small-molecule Tau-SH3 interaction inhibitors that prevent amyloid-β toxicity and network hyperexcitability

Jonathan R Roth, J. Day, Hunter B. Dean, 2023, Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics.

P.2.b.008 In vitro effects of the multimodal antidepressant Lu AA21004 at human and rat 5-HT1A, 5-HT1B, 5-HT3 and 5-HT7 receptors, and 5-HT transporters

C. Sánchez, M. Hentzer, T. Stensbøl, 2012, European Neuropsychopharmacology.